Skip to main content

Table 1 Clinical and demographic features of the patient groups included in the study (PA=peanut allergic patients, PS=peanut sensitized patients, C=healthy controls)

From: Use of a basophil activation test as a complementary diagnostic tool in the diagnosis of severe peanut allergy in adults

 

PA (n = 47)

PS (n = 22)

C (n = 22)

Men

25

7

5

Women

22

15

11

Age (mean)

25

28

33

Sensitization to peanut (sIgE)

47

20

-

Sensitization to peanut (SPT)

47

18

-

Sensitization to birch (sIgE)

36

20

-

Sensitization to birch (SPT)

34

18

-

Sensitization to soy (IgE)

34

11

-

Sensitization to soy (SPT)

19

13

-

Asthma

31

11

-

Immunotherapy (birch pollen)

5

3

-

Open peanut challenge during allergy investigation

8

22

-

Peanut avoidance

47

7

-

Soy avoidance

19

5

-